Literature DB >> 8238226

Predicted outcome from hypotensive therapy for glaucomatous optic neuropathy.

E M Van Buskirk1, G A Cioffi.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8238226     DOI： 10.1016/s0002-9394(14)73208-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  4 in total

Review 1.  Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  S S Patel; C M Spencer
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 2.  Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.

Authors:  J A Balfour; M I Wilde
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

3.  Hypercapnia invokes an acute loss of contrast sensitivity in untreated glaucoma patients.

Authors:  S L Hosking; D W Evans; S J Embleton; B Houde; J F Amos; J D Bartlett
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

4.  Evidence-based approach to glaucoma management.

Authors:  Chandrasekhar Garudadri; Sirisha Senthil; Harsha Laxmana Rao
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.